Posted May 30, 2017 by admin in articles
 
 

Global Biopharmaceuticals Manufacturing Market: Industry Analysis and Forecast 2021

6
6

Biopharmaceutical products are manufactured, or semi-synthesised from biological sources including vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, etc. These drugs are considered more effective than pharmaceutical drugs in treating various chronic diseases and intractable medical conditions such as cancer and autoimmune disease. The latest report by IMARC Group titled, “Global Biopharmaceutical Manufacturing Market Report 2017-2021”, provides a detailed analysis of the global biopharmaceutical manufacturing market. According to the report, the global biopharmaceuticals manufacturing market reached a value of more than US$ 150 Billion in 2016, growing at a CAGR of 9% in 2009-2016.

 

Request Sample of the Report: http://www.imarcgroup.com/request?type=report&id=724&flag=B

 

Biopharmaceuticals are primarily manufactured in both, academic and industrial laboratories under highly complex manufacturing techniques. The genetically engineered cells are frozen and kept in storage which are later made to grow in the unusual environment of a reaction vessel. The molecules thus formed are segregated from the living cells which produced them and the media in which they were made. All this is achieved without damaging their complex and fragile structures. The manufacturing process is time-consuming and involves high costs, expensive raw materials, offer low yields and require a team of highly-skilled experts to operate them.

 

Despite of high costs of manufacturing and production complexity, the biopharmaceuticals drugs have witnessed growth in demand. This has largely been a result of increase in investments in biotech R&D. Apart from this, the manufacturers are also introducing cost-effective techniques of manufacturing by finding new ways to improve the performance of the production process; adopting new technologies; and fostering equipment utilisation.  On the other hand, the government is also playing an active role in encouraging the production and distribution of these drugs. The manufacturing firms are provided with subsides by the governments which makes the production of biopharmaceutical drugs more affordable and less risky. Owing to these factors, the market is expected to reach a value of nearly US$ 250 Billion by 2022.

 

Browse summary of the report with TOC:

http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market

 

Mammalian-cell based products account for the largest market share

The global biopharmaceutical manufacturing market has been categorized on the basis of cell-culture which includes mammalian-cell culture and microbial-cell culture. There has been an increase in the mammalian-cell based products as these are known to cause minimum adverse reactions. As a result of this, mammalian-cell culture based biopharmaceutical products account for the largest share in the biopharmaceutical cell culture market.

 

North America represents the largest market for biopharmaceuticals drugs

An analysis of the competitive landscape finds that North America dominates the global biopharmaceuticals industry owing to technological advancements and improvement in healthcare infrastructure. North America is followed by Europe and Asia, with the latter representing the fastest growing market. Increasing trends of contract manufacturing, rising population, improving standards of living and growing health consciousness are the factors which are driving the market in this region. An evaluation of the competitive landscape provides details of the key players operating in the market. Some of the major players include Pfizer Inc., Roche, Amgen Inc. Novo Nordisk, AbbVie Inc, Sanofi S.A, Eli Lilly, Johnson & Johnson, Merck Co., etc.

 

About Us:

IMARC Group is a leading market research and consulting company that offers management strategy and market research worldwide. The company has done multiple projects on the portable medical and healthcare devices industry, which has enabled the clients to successfully set up and expand their businesses. Some of the company’s offerings include:

  • Market Research
  • Plant setup
  • Plant Expansion
  • Marketing and sales
  • Procurement and Distribution
  • Innovation and Product Development

 

For more information, please visit: http://www.imarcgroup.com/



Views Count:355 views
  • Join Our Newsletter

    Signup today for free and be the first to get notified on News updates.


admin